News

Simulations Plus has released GastroPlus Version 6.1, the latest version of its software used by pharmaceutical research scientists for simulation of oral absorption, intravenous dosing, pharmacokinetics, and pharmacodynamics.

Addex Pharmaceuticals has announced today that in a non-human primate model of Parkinson’s disease (PD) levodopa induced dyskinesia (LID), ADX48621 inhibited dose dependently both chorea and dystonia, the

France-based Servier has inaugurated a new manufacturing plant. The facility will also act as R&D center for the company. The facility will be based in Arklow, County Wicklow,

PURE Bioscience has entred into an agreement with Charlotte Products, whereby Charlotte Products will blend and package PURE’s patented silver dihydrogen citrate (SDC)-based hard surface disinfectant, which will

The Automation Partnership (TAP) has reported that its Advanced Projects Group has successfully collaborated with a major European antibody therapeutics company to deliver a custom automated protein purification

Boston Scientific has reported that it is planing to close the Florida’s stent manufacturing plant and is expected to move 1,400 jobs from the Miami area to Costa

Roche and the Department of Health of Junta de Andalucia, Spain, have signed an agreement for a co-operation in the Medical Genome Project (MGP). Its a research project

Shire has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency for velaglucerase alfa, the company’s enzyme replacement therapy in development, for the treatment of Type

YM BioSciences has reported that Cytopia has commenced enrollment of a Phase I/II trial evaluating Cyt387, a potent, orally-administered JAK1/JAK2 inhibitor. The trial is being conducted at Mayo